全球治疗诊断市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

全球治疗诊断市场预计将大幅成长，到 2033 年将达到 97.8 亿美元，高于 2024 年的 29.8 亿美元。预计 2025 年至 2033 年期间该市场的年复合成长率(CAGR) 为 14.11%。

全球治疗诊断市场有望在个人化医疗（将诊断检测与标靶治疗相结合）的推动下快速成长。分子影像、生物标记识别和伴随诊断领域的创新，正在实现精准的患者分层和治疗监测。未来的发展将专注于整合人工智慧和机器学习，以提高预测准确性并优化治疗效果。

此外，癌症和神经系统疾病等慢性疾病的盛行率不断上升，也扩大了对诊疗解决方案的需求。监管支持和不断增长的研发投入正在加速市场应用。基因组学、蛋白质组学和奈米技术的融合正在催生新型诊疗药物。随着医疗保健向精准医疗转型，诊疗市场将持续创新，提供量身定制、有效且经济高效的医疗保健解决方案。

目录

第一章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：治疗诊断 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 按产品进行的市场吸引力分析
  • 市场吸引力分析：按应用
  • 按最终用途进行的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第五章：全球治疗诊断市场分析：按产品

• 按产品概览
• 按产品进行的历史和预测数据分析
• 诊断影像
• 放射性药物
• 体外诊断/生物标记筛检
• 软体和服务

第六章：全球治疗诊断市场分析：按应用

• 概述：按应用
• 历史和预测数据分析：按应用
• 摄护腺癌
• 骨转移
• 神经内分泌肿瘤
• 淋巴瘤
• 心血管疾病
• 其他

第七章：全球治疗诊断市场分析：依最终用途

• 按最终用途概述
• 按最终用途进行的历史和预测数据分析
• 医院
• 诊断中心
• 专科诊所
• 其他

第 8 章：全球治疗诊断市场分析：按地区

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第九章：治疗诊断公司的竞争格局

• 治疗诊断市场竞争
• 伙伴关係/合作/协议
• 併购
• 新产品发布
• 其他发展

第十章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Bayer AG
• 公司概况
• 公司收入
• 产品
• 最新动态
• Beckman Coulter Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Cardinal Health Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Canon Medical Systems Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• Curium
• 公司概况
• 公司收入
• 产品
• 最新动态
• F. Hoffmann La Roche Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• GE HealthCare Technologies Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Koninklijke Philips NV
• 公司概况
• 公司收入
• 产品
• 最新动态
• Lantheus Holdings Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Siemens Healthnieers AG
• 公司概况
• 公司收入
• 产品
• 最新动态
• Thermo Fisher Scientific Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

Global Theranostics Market is poised to witness substantial growth, reaching a value of USD 9.78 Billion by the year 2033, up from USD 2.98 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 14.11% between 2025 and 2033.

The global theranostics market is poised for rapid growth driven by advancements in personalized medicine that combine diagnostic testing with targeted therapy. Innovations in molecular imaging, biomarker identification, and companion diagnostics are enabling precise patient stratification and treatment monitoring. Future developments will focus on integrating AI and machine learning to enhance predictive accuracy and optimize therapeutic outcomes.

Moreover, increasing prevalence of chronic diseases such as cancer and neurological disorders is expanding demand for theranostic solutions. Regulatory support and growing investments in R&D are accelerating market adoption. The convergence of genomics, proteomics, and nanotechnology is fostering novel theranostic agents. As healthcare shifts towards precision medicine, the theranostics market will continue to innovate, delivering tailored, effective, and cost-efficient healthcare solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Theranostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Diagnostic Imaging
• Radiopharmaceuticals
• IVD/Biomarker Screeening
• Software And Services

By Application

• Prostate Cancer
• Bone Metastasis
• Neuroendocrine Tumors
• Lymphoma
• Cardiovascular Diseases
• Other

By End-Use

• Hospitals
• Diagnostics Centers
• Specialty Clinics
• Other
• List of Companies Profiled in the report
• Bayer AG, Beckman Coulter Inc., Cardinal Health Inc., Canon Medical Systems Corporation, Curium, F. Hoffmann La Roche Ltd., GE HealthCare Technologies Inc., Koninklijke Philips N.V., Lantheus Holdings Inc., Siemens Healthnieers AG, Thermo Fisher Scientific Inc.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. THERANOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-Use
  • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL THERANOSTICS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Diagnostic Imaging Historic and Forecast Sales By Regions
• 5.4. Radiopharmaceuticals Historic and Forecast Sales By Regions
• 5.5. Ivd/Biomarker Screeening Historic and Forecast Sales By Regions
• 5.6. Software And Services Historic and Forecast Sales By Regions

6. GLOBAL THERANOSTICS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Prostate Cancer Historic and Forecast Sales By Regions
• 6.4. Bone Metastasis Historic and Forecast Sales By Regions
• 6.5. Neuroendocrine Tumors Historic and Forecast Sales By Regions
• 6.6. Lymphoma Historic and Forecast Sales By Regions
• 6.7. Cardiovascular Diseases Historic and Forecast Sales By Regions
• 6.8. Other Historic and Forecast Sales By Regions

7. GLOBAL THERANOSTICS MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-Use
• 7.2. Historical and Forecast Data Analysis By End-Use
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Diagnostics Centers Historic and Forecast Sales By Regions
• 7.5. Specialty Clinics Historic and Forecast Sales By Regions
• 7.6. Other Historic and Forecast Sales By Regions

8. GLOBAL THERANOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE THERANOSTICS COMPANIES

• 9.1. Theranostics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF THERANOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Bayer AG
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Beckman Coulter Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Cardinal Health Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Canon Medical Systems Corporation
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Curium
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. F. Hoffmann La Roche Ltd.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. GE HealthCare Technologies Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Koninklijke Philips N.V.
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Lantheus Holdings Inc.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Siemens Healthnieers AG
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Thermo Fisher Scientific Inc
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Diagnostic Imaging Market Sales By Geography (USD MN)
• Radiopharmaceuticals Market Sales By Geography (USD MN)
• Ivd/Biomarker Screeening Market Sales By Geography (USD MN)
• Software And Services Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Prostate Cancer Market Sales By Geography (USD MN)
• Bone Metastasis Market Sales By Geography (USD MN)
• Neuroendocrine Tumors Market Sales By Geography (USD MN)
• Lymphoma Market Sales By Geography (USD MN)
• Cardiovascular Diseases Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Diagnostics Centers Market Sales By Geography (USD MN)
• Specialty Clinics Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Theranostics Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Theranostics Report
• Market Research Process
• Market Research Methodology
• Global Theranostics Market Size, By Regions (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-Use
• Market Attractiveness Analysis By Regions
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Diagnostic Imaging Market Sales By Geography (USD MN)
• Radiopharmaceuticals Market Sales By Geography (USD MN)
• Ivd/Biomarker Screeening Market Sales By Geography (USD MN)
• Software And Services Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Prostate Cancer Market Sales By Geography (USD MN)
• Bone Metastasis Market Sales By Geography (USD MN)
• Neuroendocrine Tumors Market Sales By Geography (USD MN)
• Lymphoma Market Sales By Geography (USD MN)
• Cardiovascular Diseases Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Diagnostics Centers Market Sales By Geography (USD MN)
• Specialty Clinics Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.